Vaccines and COVID-19
Last Update: Aug 08, 2022
This page lists emerging information and publications in COVID-19 Genomics and Precision Health portal that are relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages.
Recent Publications
-
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.
Rivera Juan Carlos H Hernández, et al. Transplantation proceedings 2022 0 0.
-
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.
Korodi Mónika, et al. Vaccine 2022 0 0.
-
Clinical Characteristics of Pediatric Patients With COVID-19 between Omicron era vs. Pre-Omicron era.
Iijima Hiroyuki, et al. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2022 0 0.
-
Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants.
Zou Lirong, et al. Journal of medical virology 2022 0 0.
-
Maintaining genomic surveillance using whole-genome sequencing of SARS-CoV-2 from rapid antigen test devices
GE Martin et al, he Lancet Infectious Diseases, August 4, 2022
Genomic sequencing of SARS-CoV-2 has had a major role in the public health response to the COVID-19 pandemic, enabling mapping of viral transmission at global and local levels, informing infection control measures, and, importantly, identifying and tracking the emergence of new SARS-CoV-2 variants. The rapid detection and characterization of new variants is crucial for informing the potential efficacy of vaccines and therapeutics. -
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.
Pastorio Chiara, et al. Cell host & microbe 2022 0 0.
-
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
Medits Iris, et al. Frontiers in immunology 2022 0 0. 946318
-
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022.
Amati Rebecca, et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2022 0 0. (31)
-
Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19.
Ghasemi Ali, et al. Current drug safety 2022 0 0.
-
Effectiveness of mRNA booster vaccine among health Care workers in New York City during the omicron surge, December 2021- January 2022.
Robilotti Elizabeth V, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2022 0 0.
-
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
Ferreira Victor H, et al. Nature communications 2022 0 0. (1) 4489
-
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
Dolton Garry, et al. Cell 2022 0 0. (16) 2936-2951.e19
-
A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols.
Shamsi Gamchi N, et al. The European journal of health economics : HEPAC : health economics in prevention and care 2022 0 0.
-
[Clinical study of awake prone positioning treatment in patients with common coronavirus disease 2019 caused by Omicron variant].
Wang Zhiyong, et al. Zhonghua wei zhong bing ji jiu yi xue 2022 0 0. (6) 576-580
-
[Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].
Guo Xiaoguang, et al. Zhonghua wei zhong bing ji jiu yi xue 2022 0 0. (6) 581-585
-
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation.
Marcacci Gianpaolo, et al. Infectious agents and cancer 2022 0 0. (1) 41
-
Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections.
Zou Jing, et al. mBio 2022 0 0. e0199622
-
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan Wuqiang, et al. Journal of virology 2022 0 0. e0048022
-
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study.
Edward Priya R, et al. Journal of the Pediatric Infectious Diseases Society 2022 0 0.
-
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
Suntronwong Nungruthai, et al. Journal of medical virology 2022 0 0.
Get All Vacccine Records
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 08, 2022
- Content source: